Today, we’d like to introduce our close partner Sphereon, a software development company specialized in the integration of enterprise content management systems and their business processes with blockchain technology. Together with...Read More
Last week, Triall featured on Cointelegraph China. The article, written by Chinese journalist Anderson Li, explains how Triall aims to tackle some of the persistent issues currently felt by the...Read More
Last week, Triall presented at the Utrecht Blockchain Nights to discuss the relevance of blockchain-based mechanisms for clinical trials and international cooperation during infectious disease outbreaks. The night was hosted by Lisk...Read More
In an increasingly mobile and expeditious world, outbreaks of known or emerging infectious diseases are a real and unavoidable threat. For this reason, it’s vital that we have the right...Read More
As the number of blockchain protocols and platforms has increased significantly over the past 3 years, it can be challenging for enterprises to identify the best for building their blockchain-enabled...Read More
In part 1 and part 2 of this series, we explained how blockchain technology can be leveraged to enhance the integrity, auditability, and exchange of data in clinical trials. In this article, we will...Read More
In part 1 of this series, we explained how blockchain technology can be leveraged to enhance data integrity, auditability, and traceability in clinical trials. In this article, we dive into other unique...Read More
In a previous article, we introduced clinical trials and explained why they are so important to our health systems. In this article, we will address how blockchain technology can play a...Read More
Triall today announces that it will be presenting at the ClinOpsDag 2019 (‘Clinical Operations Day’) event on the 15th of May. As part of the event, Joost Flach, Triall’s director...Read More